BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25391651)

  • 1. miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.
    Liang H; Liu M; Yan X; Zhou Y; Wang W; Wang X; Fu Z; Wang N; Zhang S; Wang Y; Zen K; Zhang CY; Hou D; Li J; Chen X
    J Biol Chem; 2015 Jan; 290(2):926-40. PubMed ID: 25391651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
    Yu T; Li J; Yan M; Liu L; Lin H; Zhao F; Sun L; Zhang Y; Cui Y; Zhang F; Li J; He X; Yao M
    Oncogene; 2015 Jan; 34(4):413-23. PubMed ID: 24469061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-associated silencing of
    Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
    Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
    Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
    Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.
    Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC
    Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
    Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
    Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
    Fan Q; Hu X; Zhang H; Wang S; Zhang H; You C; Zhang CY; Liang H; Chen X; Ba Y
    Cell Physiol Biochem; 2017; 44(4):1311-1324. PubMed ID: 29183007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-193a-3p Promotes Radio-Resistance of Nasopharyngeal Cancer Cells by Targeting SRSF2 Gene and Hypoxia Signaling Pathway.
    Kong L; Wei Q; Hu X; Chen L; Li J
    Med Sci Monit Basic Res; 2019 Feb; 25():53-62. PubMed ID: 30773530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00152 down-regulated
    Huang Y; Luo H; Li F; Yang Y; Ou G; Ye X; Li N
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29339419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
    Williams M; Kirschner MB; Cheng YY; Hanh J; Weiss J; Mugridge N; Wright CM; Linton A; Kao SC; Edelman JJ; Vallely MP; McCaughan BC; Cooper W; Klebe S; Lin RC; Brahmbhatt H; MacDiarmid J; van Zandwijk N; Reid G
    Oncotarget; 2015 Sep; 6(27):23480-95. PubMed ID: 26125439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1.
    Kwon JE; Kim BY; Kwak SY; Bae IH; Han YH
    Apoptosis; 2013 Jul; 18(7):896-909. PubMed ID: 23546867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
    Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
    Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
    Hiraide S; Takahashi M; Yoshida Y; Yamada H; Komine K; Ishioka C
    Cancer Sci; 2021 Sep; 112(9):3856-3870. PubMed ID: 34288281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-548b-3p functions as a tumor suppressor in lung cancer.
    Wang Z; Wu X; Hou X; Zhao W; Yang C; Wan W; Chen L
    Lasers Med Sci; 2020 Jun; 35(4):833-839. PubMed ID: 31485783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
    Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK
    Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
    Pekow J; Meckel K; Dougherty U; Huang Y; Chen X; Almoghrabi A; Mustafi R; Ayaloglu-Butun F; Deng Z; Haider HI; Hart J; Rubin DT; Kwon JH; Bissonnette M
    Clin Cancer Res; 2017 Sep; 23(17):5281-5291. PubMed ID: 28600480
    [No Abstract]   [Full Text] [Related]  

  • 19. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
    Dong Z; Liu H; Zhao G
    Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
    [No Abstract]   [Full Text] [Related]  

  • 20. PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p.
    Yu M; Liu Z; Liu Y; Zhou X; Sun F; Liu Y; Li L; Hua S; Zhao Y; Gao H; Zhu Z; Na M; Zhang Q; Yang R; Zhang J; Yao Y; Chen X
    FEBS J; 2019 Mar; 286(6):1136-1153. PubMed ID: 30548198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.